Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.

Glycogen-specific kinase (GSK3β) is an integral regulator of the Wnt signalling pathway as well as many other diverse signalling pathways and processes. Dys-regulation of GSK3β is implicated in many different pathologies, including neurodegenerative disorders as well as many different tumour types....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emily Bowler-Barnett, Francisco D Martinez-Garcia, Matthew Sherwood, Ahood Aleidan, Steve John, Sara Weston, Yihua Wang, Nullin Divecha, Paul Skipp, Rob M Ewing
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2a412eacc29f48f1be41448779881b8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2a412eacc29f48f1be41448779881b8f
record_format dspace
spelling oai:doaj.org-article:2a412eacc29f48f1be41448779881b8f2021-12-02T20:06:04ZProteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.1932-620310.1371/journal.pone.0246707https://doaj.org/article/2a412eacc29f48f1be41448779881b8f2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0246707https://doaj.org/toc/1932-6203Glycogen-specific kinase (GSK3β) is an integral regulator of the Wnt signalling pathway as well as many other diverse signalling pathways and processes. Dys-regulation of GSK3β is implicated in many different pathologies, including neurodegenerative disorders as well as many different tumour types. In the context of tumour development, GSK3β has been shown to play both oncogenic and tumour suppressor roles, depending upon tissue, signalling environment or disease progression. Although multiple substrates of the GSK3β kinase have been identified, the wider protein networks within which GSK3β participates are not well known, and the consequences of these interactions not well understood. In this study, LC-MS/MS expression analysis was performed using knockout GSK3β colorectal cancer cells and isogenic controls in colorectal cancer cell lines carrying dominant stabilizing mutations of β-catenin. Consistent with the role of GSK3β, we found that β-catenin levels and canonical Wnt activity are unaffected by knockout of GSK3β and therefore used this knockout cell model to identify other processes in which GSK3β is implicated. Quantitative proteomic analysis revealed perturbation of proteins involved in cell-cell adhesion, and we characterized the phenotype and altered proteomic profiles associated with this. We also characterized the perturbation of metabolic pathways resulting from GSK3β knockout and identified defects in glycogen metabolism. In summary, using a precision colorectal cancer cell-line knockout model with constitutively activated β-catenin we identified several of the diverse pathways and processes associated with GSK3β function.Emily Bowler-BarnettFrancisco D Martinez-GarciaMatthew SherwoodAhood AleidanSteve JohnSara WestonYihua WangNullin DivechaPaul SkippRob M EwingPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11, p e0246707 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Emily Bowler-Barnett
Francisco D Martinez-Garcia
Matthew Sherwood
Ahood Aleidan
Steve John
Sara Weston
Yihua Wang
Nullin Divecha
Paul Skipp
Rob M Ewing
Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
description Glycogen-specific kinase (GSK3β) is an integral regulator of the Wnt signalling pathway as well as many other diverse signalling pathways and processes. Dys-regulation of GSK3β is implicated in many different pathologies, including neurodegenerative disorders as well as many different tumour types. In the context of tumour development, GSK3β has been shown to play both oncogenic and tumour suppressor roles, depending upon tissue, signalling environment or disease progression. Although multiple substrates of the GSK3β kinase have been identified, the wider protein networks within which GSK3β participates are not well known, and the consequences of these interactions not well understood. In this study, LC-MS/MS expression analysis was performed using knockout GSK3β colorectal cancer cells and isogenic controls in colorectal cancer cell lines carrying dominant stabilizing mutations of β-catenin. Consistent with the role of GSK3β, we found that β-catenin levels and canonical Wnt activity are unaffected by knockout of GSK3β and therefore used this knockout cell model to identify other processes in which GSK3β is implicated. Quantitative proteomic analysis revealed perturbation of proteins involved in cell-cell adhesion, and we characterized the phenotype and altered proteomic profiles associated with this. We also characterized the perturbation of metabolic pathways resulting from GSK3β knockout and identified defects in glycogen metabolism. In summary, using a precision colorectal cancer cell-line knockout model with constitutively activated β-catenin we identified several of the diverse pathways and processes associated with GSK3β function.
format article
author Emily Bowler-Barnett
Francisco D Martinez-Garcia
Matthew Sherwood
Ahood Aleidan
Steve John
Sara Weston
Yihua Wang
Nullin Divecha
Paul Skipp
Rob M Ewing
author_facet Emily Bowler-Barnett
Francisco D Martinez-Garcia
Matthew Sherwood
Ahood Aleidan
Steve John
Sara Weston
Yihua Wang
Nullin Divecha
Paul Skipp
Rob M Ewing
author_sort Emily Bowler-Barnett
title Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
title_short Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
title_full Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
title_fullStr Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
title_full_unstemmed Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
title_sort proteomic characterization of gsk3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/2a412eacc29f48f1be41448779881b8f
work_keys_str_mv AT emilybowlerbarnett proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT franciscodmartinezgarcia proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT matthewsherwood proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT ahoodaleidan proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT stevejohn proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT saraweston proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT yihuawang proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT nullindivecha proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT paulskipp proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
AT robmewing proteomiccharacterizationofgsk3bknockoutshowsalteredcelladhesionandmetabolicpathwayutilisationincolorectalcancercells
_version_ 1718375412700020736